MedPath

Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology

Completed
Conditions
Cancer Stem Cells
Postoperative Recurrence and Metastasis
Hepatocellular Carcinoma
Registration Number
NCT02727673
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Brief Summary

The aim of this study is to establish a platform of detecting and sorting circulating tumor stem cells from peripheral blood in HCC patients; to investigate the relationship between circulating tumor stem cells and their effects on postoperative recurrence and metastasis, in order to provide a new therapeutic target for hepatocellular carcinoma treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1000
Inclusion Criteria
  1. Male or female patients > 18 years and <=70 years of age;
  2. No dysfunction in major organs; Blood routine, kidney function, cardiac function and lung function are basically normal.
  3. Patients who can understand this trial and have signed information consent
Exclusion Criteria
  1. Reject to attend;
  2. Impossible to come to our hospital for physical examination regularly;
  3. Patients with other diseases which may affect the treatment mentioned

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the overall survival rate of each group3 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Eastern hepatobilliary surgery hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath